AFYREN

AFYREN operates in the bioeconomy sector, focusing on producing biomolecules that serve as sustainable alternatives to petrochemical products. The company targets industrial clients seeking to reduce their ecological footprint by integrating biobased solutions into their production processes. AFYREN's business model revolves around leveraging its proprietary technology to manufacture a range of organic acids, which are used as ingredients in various applications. Revenue is generated through the sale of these biobased products, which are positioned as environmentally friendly and compliant with international standards for natural raw materials. The company operates its first manufacturing plant, AFYREN NEOXY, in collaboration with the SPI Fund, highlighting its commitment to industrial partnerships. AFYREN's market strategy is aligned with the global shift towards a circular and regenerative economy, aiming to contribute to better health for people and ecosystems. The company's approach is characterized by adaptability to the evolving needs of its clients and society, ensuring its relevance in a rapidly changing world. Keywords: biomolecules, bioeconomy, organic acids, sustainability, low-carbon, biobased, petrochemical alternatives, ecological footprint, circular economy, regenerative.